These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 12050863)

  • 1. Molecular diagnosis of cystic fibrosis.
    Shrimpton AE
    Expert Rev Mol Diagn; 2002 May; 2(3):240-56. PubMed ID: 12050863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular diagnosis of cystic fibrosis.
    Kant JA; Mifflin TE; McGlennen R; Rice E; Naylor E; Cooper DL
    Clin Lab Med; 1995 Dec; 15(4):877-98. PubMed ID: 8838228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cystic fibrosis: the CFTR gene, its mutations, the genetic counseling].
    Goossens M; Ghanem N; Girodon E; Costes B; Fanen P
    Rev Pneumol Clin; 1995; 51(3):130-6. PubMed ID: 7569574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The type and frequency of mutations in CFTR gene occurrence in patients with cystic fibrosis in Poland--implication of results obtained from genetic counseling and diagnostic screening].
    Bal J; Maciejko D; Mazurczak T
    Pediatr Pol; 1995 Aug; 70(8):627-32. PubMed ID: 8668362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction to molecular cystic fibrosis testing.
    Uphoff TS; Highsmith WE
    Clin Lab Sci; 2006; 19(1):24-31. PubMed ID: 16617555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier screening for cystic fibrosis.
    Dungan JS
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):47-59, Table of Contents. PubMed ID: 20494257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn screening for cystic fibrosis.
    Wallace J; Stein Q
    S D Med; 2006 Oct; 59(10):429-31. PubMed ID: 17124920
    [No Abstract]   [Full Text] [Related]  

  • 8. Newborn screening for cystic fibrosis in New York State.
    Caggana M; Helton L
    Pediatrics; 2007 Jul; 120(1):241; author reply 241-3. PubMed ID: 17606589
    [No Abstract]   [Full Text] [Related]  

  • 9. First DNA-based test to detect cystic fibrosis.
    FDA Consum; 2005; 39(4):4. PubMed ID: 16252390
    [No Abstract]   [Full Text] [Related]  

  • 10. Outcome of intracytoplasmic sperm injection for a couple in which the man is carrier of CFTR p.[R74W;V201M;D1270N] and p.P841R mutations and his spouse a heterozygous carrier of p.F508del mutation of the cystic fibrosis transmembrane conductance regulator gene.
    Brugnon F; Bilan F; Heraud MC; Grizard G; Janny L; Creveaux I
    Fertil Steril; 2008 Nov; 90(5):2004.e23-6. PubMed ID: 18703181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis.
    Mayell SJ; Munck A; Craig JV; Sermet I; Brownlee KG; Schwarz MJ; Castellani C; Southern KW;
    J Cyst Fibros; 2009 Jan; 8(1):71-8. PubMed ID: 18957277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal screening for cystic fibrosis: past, present and future.
    Richards CS; Grody WW
    Expert Rev Mol Diagn; 2004 Jan; 4(1):49-62. PubMed ID: 14711349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cystic fibrosis and neonatal screening].
    Nau JY
    Rev Med Suisse; 2007 May; 3(110):1212. PubMed ID: 17564353
    [No Abstract]   [Full Text] [Related]  

  • 14. Negative genetic neonatal screening for cystic fibrosis caused by compound heterozygosity for two large CFTR rearrangements.
    Girardet A; Guittard C; Altieri JP; Templin C; Stremler N; Beroud C; des Georges M; Claustres M
    Clin Genet; 2007 Oct; 72(4):374-7. PubMed ID: 17850636
    [No Abstract]   [Full Text] [Related]  

  • 15. [National program for neonatal screening for cystic fibrosis: implementation and preliminary results].
    Navarro J; Grosskopf C; Vidailhet M; Briard ML; Farriaux JP
    J Gynecol Obstet Biol Reprod (Paris); 2003 Feb; 32(1 Suppl):1S56-60. PubMed ID: 12592165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Functional characterization of naturally occurring CFTR mutants: interest for cystic fibrosis].
    Romey MC
    Ann Biol Clin (Paris); 2006; 64(5):429-37. PubMed ID: 17040873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orchid BioSciences launches ELUCIGENE CF29 screening test.
    Expert Rev Mol Diagn; 2001 Sep; 1(3):245. PubMed ID: 11901821
    [No Abstract]   [Full Text] [Related]  

  • 18. Applying CFTR molecular genetics to facilitate the diagnosis of cystic fibrosis through screening.
    Bobadilla JL; Farrell MH; Farrell PM
    Adv Pediatr; 2002; 49():131-90. PubMed ID: 12214770
    [No Abstract]   [Full Text] [Related]  

  • 19. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
    Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
    BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic counselling issues in cystic fibrosis.
    Culling B; Ogle R
    Paediatr Respir Rev; 2010 Jun; 11(2):75-9. PubMed ID: 20416541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.